Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hucircadian
With
Korea University Guro Hospital
Korea University Ansan Hospital
Pusan National University Hospital
Inje University Ilsan Paik Hospital
Age
19–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients, 19-70 years old
Diagnosis with Bipolar I disorder, Bipolar II disorder, Major depressive disorder based on DSM-5 criteria, in euthymic state for more than two weeks at the time of the recruitment
Android smartphone users, capable of installing and executing the CRM application
Consent to wear wearable device (Fitbit) continuously and synchronize and backup data regularly
You may not be if
Patients who have not experienced major depressive, manic, or hypomanic episode in the last two years
Patients who are difficult to specify mood episode or evaluate symptoms of mood episode independently due to personality traits (borderline personality trait, cyclothymic temperament, etc.)
Patients with degenerative neurological disorders (Parkinson's disease, dementia, Huntington's disease, etc.), neurodevelopmental disorders (intellectual disorder, autism spectrum disorder, down syndrome, etc.), epilepsy, severe traumatic brain damage, stroke, and other brain neurological disorders
Inmates or patients who are forced into custody for the treatment of mental or physical illness (non-voluntary isolation or hospitalization)
Patients with difficulties in understanding the objectives and process of the study and the potential benefits and risks of participating in the study
Clareo Health | Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning
